Success Metrics

Clinical Success Rate
20.0%

Based on 1 completed trials

Completion Rate
20%(1/5)
Active Trials
2(17%)
Results Posted
0%(0 trials)
Terminated
4(33%)

Phase Distribution

Ph early_phase_1
1
8%
Ph not_applicable
8
67%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

14.3%

1 of 7 finished

Non-Completion Rate

85.7%

6 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(1)
Terminated(6)
Other(3)

Detailed Status

Terminated4
unknown3
Recruiting2
Withdrawn2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
20.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (11.1%)
N/A8 (88.9%)

Trials by Status

completed18%
recruiting217%
terminated433%
unknown325%
withdrawn217%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DEVICE
Total Trials
12